针对Clostridioides difficile毒素TcdA和TcdB的小鼠单克隆抗体针对不同的表位基因进行中和
Heather K Kroh1, Jaime L Jensen1, Sabine Wellnitz2
1Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Infection and immunity
|August 22, 2025
概括
研究人员发现对Clostridioides difficile毒素A和B的小鼠单克隆抗体具有中和作用. 这些抗体会干扰毒素的活性,为抗击C. difficile感染提供潜在的治疗策略.
科学领域:
- 微生物学
- 免疫学
- 毒理学
背景情况:
- 困难菌是病房感染的主要原因,导致虚膜性结肠炎和与抗生素相关的腹.
- 这种细菌的毒性主要由大型克洛斯特毒素A (TcdA) 和B (TcdB) 介导,这些毒素会破坏宿主细胞细胞骨架.
- 目前的治疗方法有限, 凸显出需要新的治疗方法.
研究的目的:
- 发现和描述对Clostridioides difficile毒素进行中和的小鼠单克隆抗体.
- 阐明这些抗体中和毒素活动的机制.
- 调查使用毒素或毒素诱导中和抗体反应的可能性.
主要方法:
- 使用混合体技术产生单克隆抗体.
- 用毒素中和功能测试来评估抗体的有效性和机制.
- 使用-交换质谱,阴性染色和冷电子显微镜绘制抗体结合表位.
主要成果:
- 成功生成了一组中和小鼠单克隆抗体.
- 这些抗体被证明会干扰细胞中毒的各个阶段.
- 鉴定了抗体所使用的特定的中和机制.
- 在抗体上发现了毒素的详细结合点.
结论:
- 这项研究成功地鉴定和鉴定了对C. difficile毒素的中和单克隆抗体.
- 这些抗体为开发针对C. difficile感染的新疗法提供了有希望的途径.
- 使用改性毒素或毒素诱导中和抗体是一种可行的策略.
更多相关视频
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
10.2K
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
7.0K
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...